Exhibit 99.1
Ad hoc Release
Publication of inside information pursuant to Article 17 MAR
Biofrontera AG announces reduction of shareholding in Biofrontera Inc. below 50%
Leverkusen, Germany, December 29, 2021 - Today, Biofrontera AG (ISIN: DE0006046113), was informed by Biofrontera Inc. (Nasdaq: BFRI) that the total amount of BFRI shares outstanding has increased due to exercises of previously issued warrants. As a result, Biofrontera AG’s shareholding in Biofrontera Inc. of 8,000,000 shares now represents approximately 47 % of the currently outstanding shares.
Thus, after legal review, Biofrontera Inc. is no longer considered a subsidiary of Biofrontera AG according to § 290 HGB.
Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611
Contact:
Biofrontera AG
Tel: +49 (0214) 87 63 2 0, Fax: +49 (0214) 87 63 290
Email: ir@biofrontera.com
Seite 1 |